Expertise in
16
conditions

Dr. Benny J. Liem

Radiation Oncology
University Of New Mexico Ems Consortium
1 University Of New Mexico, 
Albuquerque, NM 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
16
conditions
University Of New Mexico Ems Consortium
1 University Of New Mexico, 
Albuquerque, NM 

Overview

Benny Liem is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico.

Dr. Liem is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Radiation Induced Meningioma, Meningioma, and Astrocytoma.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 11 clinical trials. Dr. Liem is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in NM

Hospital Affiliations

Unm Hospital

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

University of New Mexico Ems Consortium
1 University Of New Mexico, Albuquerque, NM 87131

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Drug, Other, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: August 27, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: July 13, 2026
Intervention Type: Radiation
Study Phase: Phase 3
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Fluorouracil, Mitomycin
Study Phase: Phase 2
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Enrollment Status: Completed
Publish Date: March 13, 2026
Intervention Type: Drug
Study Drug: Ramipril
Study Phase: Phase 2
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
View 9 Less Clinical Trials

1 Total Publications

Sensitivity of patients with familial cerebral cavernous malformations to therapeutic radiation.
Sensitivity of patients with familial cerebral cavernous malformations to therapeutic radiation.
Journal: Journal of medical imaging and radiation oncology
Published: July 17, 2014
Similar Doctors
Expertise in
17
conditions
Dr. Thomas M. Schroeder
Radiation Oncology
Expertise in
17
conditions
Dr. Thomas M. Schroeder
Radiation Oncology
Referral may be required

Office

800 Bradbury Dr SE Ste 116, 
Albuquerque, NM 
 (2.0 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Thomas Schroeder is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Schroeder is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Expertise in
1
conditions
Dr. Robert R. Kuske
Radiation Oncology
Expertise in
1
conditions
Dr. Robert R. Kuske
Radiation Oncology
Referral may be required

New Mexico Oncology Hematology Consultants LTD.

4901 Lang Ave NE, 
Albuquerque, NM 
 (6.3 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Kuske is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Kuske is highly rated in 1 condition, according to our data. His clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Kuske is currently accepting new patients.

Expertise in
7
conditions
Dr. David Y. Lee
Radiation Oncology
Expertise in
7
conditions
Dr. David Y. Lee
Radiation Oncology
Referral may be required

Office

800 Bradbury Dr SE Ste 116, 
Albuquerque, NM 
 (2.0 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

David Lee is a Radiation Oncologist practicing medicine in Albuquerque, New Mexico. Dr. Lee is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Familial Pancreatic Cancer. Dr. Lee is currently accepting new patients.

Frequently Asked Questions about Dr. Benny J. Liem

Is Dr. Benny J. Liem a top-rated expert for Posterior Fossa Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Benny J. Liem is classified as an Distinguished expert for Posterior Fossa Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Benny J. Liem specialize in?

While Dr. Benny J. Liem is a Radiation Oncology, they have specific expertise in Posterior Fossa Tumor, Radiation Induced Meningioma, and Meningioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Benny J. Liem participate in research or clinical trials?

Yes. Dr. Benny J. Liem has published 1 articles and abstracts on conditions like Posterior Fossa Tumor. You can view a list of Dr. Benny J. Liem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Benny J. Liem accept my insurance?

Dr. Benny J. Liem accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Liem's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 76 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile